Samsung’s ADC segregated suite, equipped with a 500-liter reactor, supports the development and manufacture of ADC therapies.

Investors sell off AMD shares despite the company's pivot to life sciences AI, following a rating downgrade by HSBC that followed a six-month decline in the stock price.

Intravenous BCG vaccine with a built-in kill-switch was found to be at least as effective as regular tuberculosis vaccine in ...

A new predictive AI system has been developed to predict gene activity in human cells with high precision. Researchers at ...

High-resolution of cellular heterogeneity from the molecular to circuit level reveals the molecular logic driving cellular ...

View eBook In the rapidly developing field of spatial biology, researchers are working to expand our understanding of ...

Novo Nordisk and Valo Health have expanded their 16-month-old collaboration into an up-to-$4.6 billion-plus artificial ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

A new study reveals new insights into ependymal cells and astrocytes and offers a promising approach for future SCI therapies ...

Researchers eventually want to map the effects of every possible mutation on all human proteins to transform precision ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

This dynamic field has seen tremendous change in recent years. Leaders share their perspectives on what trends we can expect ...